Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Hepatitis C virus genotype 3 is cytopathic to hepatocytes: Reversal of hepatic steatosis after sustained therapeutic response.

Hepatology (Baltimore, Md.) - 1 Nov 2002

Kumar Dinesh, Farrell Geoffrey C, Fung Caroline, George Jacob

Abstract excerpt

On the basis of cross-sectional studies, it has been proposed that hepatic steatosis is a cytopathic effect of hepatitis C virus (HCV) genotype 3 but not genotype 1 infections. We tested this hypothesis by examining whether antiviral treatment altered hepatic steatosis in chronic hepatitis C. In 28 patients with genotype 1 and 34 with genotype 3 HCV, we determined the severity of steatosis in pre- and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to Biopsy
Share to Fatty Liver

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepacivirus

Share to Hepatitis C, Chronic

Share to Hepatocytes

Share to Longitudinal Studies

Share to Predictive Value of Tests

Source

Identifiers

PMID: 12395339
DOI: 10.1053/jhep.2002.36370

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Hepatitis C virus genotype 3 is cytopathic to hepatocytes: Reversal of hepatic steatosis after sustained therapeutic response.PMID 12395339Read ↗

Effect of antiviral treatment on evolution of liver steatosis in patients with chronic hepatitis C: indirect evidence of a role of hepatitis C virus genotype 3 in steatosis.Semantic proximity Read ↗

Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3.Semantic proximity Read ↗

Different mechanisms of steatosis in hepatitis C virus genotypes 1 and 3 infections.Semantic proximity Read ↗

Effect of treatment with peginterferon or interferon alfa-2b and ribavirin on steatosis in patients infected with hepatitis C.Semantic proximity Read ↗

Steatosis accelerates fibrosis development over time in hepatitis C virus genotype 3 infected patients.Semantic proximity Read ↗

The impact of steatosis on disease progression and early and sustained treatment response in chronic hepatitis C patients.Semantic proximity Read ↗

Steatosis affects chronic hepatitis C progression in a genotype specific way.Semantic proximity Read ↗

Hepatic steatosis in hepatitis C virus genotype 3 infection: does it correlate with body mass index, fibrosis, and HCV risk factors?Semantic proximity Read ↗

Impact of hepatic steatosis on viral kinetics and treatment outcome during antiviral treatment of chronic HCV infection.Semantic proximity Read ↗

Liver steatosis in chronic hepatitis C: a morphological sign suggesting infection with HCV genotype 3.Semantic proximity Read ↗

Steatosis in chronic hepatitis C: why does it really matter?Semantic proximity Read ↗

Hepatic steatosis in patients with chronic hepatitis C virus genotype 2 or 3 does not affect viral response in patients treated with peginterferon alpha-2a (40KD) (PEGASYS) plus ribavirin (COPEGUS) for 16 or 24 weeks.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.